Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hoskin

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 2018
ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancerCarl Salembier, Geert Villeirs, Berardino De Bari, et al.
The British Journal of Radiology|December 17, 2021
The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planningKevin Chiu, Peter Hoskin, Amit Gupta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGECAlfonso Gomez-Iturriaga, Nikos Tselis, Patricia Willisch, et al.
Anticancer Research|September 9, 2018
Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow ToxicitySeema Dadhania, Roberto Alonzi, Suzanne Douglas, et al.
The Lancet. Oncology|February 4, 2021
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trialPeter Hoskin, Biliana Popova, Oliver Schofield, et al.
Physics and Imaging in Radiation Oncology|August 4, 2025
Multi-institution longitudinal apparent diffusion coefficient measurements in a diffusion weighted imaging phantom at room temperatureChris Moore, Charlotte Bull, Angela Darekar, et al.
La Radiologia Medica|May 17, 2023
Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findingsJim Zhong, Russell Frood, Alan McWilliam, et al.
The Lancet. Oncology|February 4, 2021
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trialsAnanya Choudhury, Nuria Porta, Emma Hall, et al.
Medical Physics|May 9, 2024
AAPM Task Group Report 267: A joint AAPM GEC-ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapyZhe Jay Chen, X Allen Li, David J Brenner, et al.
Clinical and Translational Radiation Oncology|September 18, 2024
Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era - A systematic reviewMateusz Bilski, Katarzyna Konat-Bąska, Federico Mastroleo, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 2018
ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancerCarl Salembier, Geert Villeirs, Berardino De Bari, et al.
The British Journal of Radiology|December 17, 2021
The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planningKevin Chiu, Peter Hoskin, Amit Gupta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGECAlfonso Gomez-Iturriaga, Nikos Tselis, Patricia Willisch, et al.
Anticancer Research|September 9, 2018
Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow ToxicitySeema Dadhania, Roberto Alonzi, Suzanne Douglas, et al.
The Lancet. Oncology|February 4, 2021
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trialPeter Hoskin, Biliana Popova, Oliver Schofield, et al.
Physics and Imaging in Radiation Oncology|August 4, 2025
Multi-institution longitudinal apparent diffusion coefficient measurements in a diffusion weighted imaging phantom at room temperatureChris Moore, Charlotte Bull, Angela Darekar, et al.
La Radiologia Medica|May 17, 2023
Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findingsJim Zhong, Russell Frood, Alan McWilliam, et al.
The Lancet. Oncology|February 4, 2021
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trialsAnanya Choudhury, Nuria Porta, Emma Hall, et al.
Medical Physics|May 9, 2024
AAPM Task Group Report 267: A joint AAPM GEC-ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapyZhe Jay Chen, X Allen Li, David J Brenner, et al.
Clinical and Translational Radiation Oncology|September 18, 2024
Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era - A systematic reviewMateusz Bilski, Katarzyna Konat-Bąska, Federico Mastroleo, et al.
Pageof 25